Local incidence and outcomes of patients with pneumothorax and pneumomediastinum in COVID-19
Conclusions: Inpatient incidence of PTX and PM is 0.98%. Survival is lower (54.5%) but difficult to compare in the presence of frailty and co-morbidities.
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Jackson, K., Aujayeb, A., Aujayeb, A. Tags: Clinical problems Source Type: research
More News: Asthma | Cancer | Cancer & Oncology | Chronic Obstructive Pulmonary | COVID-19 | Emphysema | Intensive Care | Lung Cancer | Pneumothorax | Respiratory Medicine | Smokers | Stroke